Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis

JAMA

Volumn 309, Issue 7, 2013, Pages 678-688

  Zarychanski, Ryan ^a,b,c   Abou Setta, Ahmed M ^a,b   Turgeon, Alexis F ^d   Houston, Brett L ^e   McIntyre, Lauralyn ^f   Marshall, John C ^g   Fergusson, Dean A ^f  

^a UNIVERSITY OF MANITOBA   (Canada)

^b WINNIPEG REGIONAL HEALTH AUTHORITY   (Canada)

^c CANCERCARE MANITOBA   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GELATIN; HETASTARCH;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANURIA; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CRYSTALLOID; FLUID RESUSCITATION; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; URINE VOLUME;

EID: 84874007303     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.430     Document Type: Review

References (66)

1. Bunn F, Trivedi D. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev. 2012;7:CD001319.
2. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet. 2005;44(7):681-699.
3. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357(9260):911-916.
4. James MF, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth. 2011;107(5):693-702.
5. Zarychanski R, Turgeon AF, Fergusson DA, et al. Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials. Open Med. 2009;3(4):e196-e209.
6. Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S; CHEST Management Committee. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis. Anesth Analg. 2012;114(1):159-169.
7. Boldt J, Müller M, Mentges D, Papsdorf M, Hempelmann G. Volume therapy in the critically ill: is there a difference? Intensive Care Med. 1998;24(1):28-36.
8. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2012;6:CD000567.
9. Hartog CS, Skupin H, Natanson C, Sun J, Reinhart K. Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses. Intensive Care Med. 2012;38(8):1258-1271.
10. Hospital presents results of final report: committee completes investigation in the case of Dr Boldt. Akademisches Lehrkrankenhaus der Johannes Gutenberg-Universität Mainz; 2012. http://www.klilu.de/content/aktuelles- presse/pressearchiv/2012/hospital-presents-results-of-final-report-committee- completes-investigation-in-the-case-of-dr-boldt/index-ger.html. Accessed January 26, 2013.
11. Editors-in-Chief Statement Regarding Published Clinical Trials Conducted without IRB Approval by Joachim Boldt. 2011. http://www.aaeditor.org/EIC.Joint. Statement.on.Retractions.pdf. Accessed October 31, 2012.
12. Zarychanski R, Abou-Setta A, Turgeon AF, Houston BL, McIntyre L, Fergusson DA. Serious adverse events associated with the use of starch-containing intravenous fluids for volume expansion: an updated systematic review and meta-analysis. http://www.crd.york.ac.uk/PROSPERO/display-record. asp?ID=CRD42012002348. Accessed October 31, 2012.
13. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. http://handbook.cochrane.org. Accessed January 28, 2013.
14. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269.
15. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73.
16. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj:d5928.
17. Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26(1):53-77.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
19. Hayashino Y, Noguchi Y, Fukui T. Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol. 2005;15(6):235-243.
20. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
21. Zhao G, Wang C. Abstracts of the 9th Congress of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA). April 12-16, 2011. Cape Town, South Africa HPB (Oxford). 2011;13(suppl 2):1-145.
22. McIntyre LA, Fergusson D, Cook DJ, et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Can J Anaesth. 2008;55(12):819-826.
23. Nagy KK, Davis J, Duda J, Fildes J, Roberts R, Barrett J. A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. Circ Shock. 1993;40(4):289-294.
24. Haupt MT, Rackow EC. Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med. 1982;10(3):159-162.
25. Chen J, Han CM, Xia SC, Tang ZJ, Su SJ. Evaluation of effectiveness and safety of a new hydroxyethyl starch used in resuscitation of burn shock. Zhonghua Shao Shang Za Zhi. 2006;22(5):333-336.
26. Berard JP, Curt I, Piech JJ, Ruiz F. Hydroxyethylamidons versus gelatines: impact sur le cout du rempissage dans un service de reanimation. Ann Fr Anesth Reanim. 1995;14:R335.
27. Lv J, Zhao HY, Liu F, An YZ. The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock [in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012;24(1):38-41.
28. Zhu GC, Quan ZY, Shao YS, Zhao JG, Zhang YT. The study of hypertonic saline and hydroxyethyl starch treating severe sepsis [in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011;23(3):150-153.
29. Boldt J, Heesen M, Müller M, Pabsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg. 1996;83(2):254-261.
30. Boldt J, Heesen M, Padberg W, Martin K, Hempelmann G. The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients. Anaesthesia. 1996;51(6):529-535.
31. Boldt J, Heesen M, Welters I, Padberg W, Martin K, Hempelmann G. Does the type of volume therapy influence endothelial-related coagulation in the critically ill? Br J Anaesth. 1995;75(6):740-746.
32. Boldt J, Mueller M, Menges T, Papsdorf M, Hempelmann G. Influence of different volume therapy regimens on regulators of the circulation in the critically ill. Br J Anaesth. 1996;77(4):480-487.
33. Boldt J, Müller M, Heesen M, Heyn O, Hempelmann G. Influence of different volume therapies on platelet function in the critically ill. Intensive Care Med. 1996;22(10):1075-1081.
34. Boldt J, Muller M, Heesen M, Neumann K, Hempelmann GG. Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med. 1996;24(3):385-391.
35. Du XJ, Hu WM, Xia Q, et al. Hydroxyethyl starch resuscitation reduces the risk of intra-abdominal hypertension in severe acute pancreatitis. Pancreas. 2011;40(8):1220-1225.
36. Dubin A, Pozo MO, Casabella CA, et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care. 2010;25(4):659.e1-e8.
37. Vlachou E, Gosling P, Moiemen NS. Hydroxyethylstarch supplementation in burn resuscitation - a prospective randomised controlled trial. Burns. 2010;36(7):984-991.
38. Gondos T, Marjanek Z, Ulakcsai Z, et al. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Eur J Anaesthesiol. 2010;27(9):794-800.
39. Heradstveit BE, Guttormsen AB, Langørgen J, et al. Capillary leakage in post-cardiac arrest survivors during therapeutic hypothermia - a prospective, randomised study. Scand J Trauma Resusc Emerg Med. 2010;18:29. doi:10.1186/1757-7241-18-29.
40. Inal MT, Memiş D, Karamanlioglu B, Sut N. Effects of polygeline and hydroxyethyl starch solutions on liver functions assessed with LIMON in hypovolemic patients. J Crit Care. 2010;25(2):361.e1-361.e5.
41. Dolecek M, Svoboda P, Kantorová I, et al. Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. Hepatogastroenterology. 2009;56(96):1622-1628.
42. van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med. 2009;37(4):1275-1281.
43. Li F, Sun H, Han XD. The effect of different fluids on early fluid resuscitation in septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008;20(8):472-475.
44. Brunkhorst FM, Engel C, Bloos F, et al; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-139.
45. Veneman TF, Oude Nijhuis J, Woittiez AJ. Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial. Wien Klin Wochenschr. 2004;116(9-10):305-309.
46. Molnár Z, Mikor A, Leiner T, Szakmány T. Fluid resuscitation with colloids of different molecular weight in septic shock. Intensive Care Med. 2004;30(7):1356-1360.
47. Asfar P, Kerkeni N, Labadie F, Gouëllo JP, Brenet O, Alquier P. Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study. Intensive Care Med. 2000;26(9):1282-1287.
48. Younes RN, Yin KC, Amino CJ, Itinoshe M, Rocha e Silva M, Birolini D. Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World J Surg. 1998;22(1):2-5.
49. Beards SC, Watt T, Edwards JD, Nightingale P, Farragher EB. Comparison of the hemodynamic and oxygen transport responses to modified fluid gelatin and hetastarch in critically ill patients: a prospective, randomized trial. Crit Care Med. 1994;22(4):600-605.
50. Rackow EC, Mecher C, Astiz ME, Griffel M, Falk JL, Weil MH. Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med. 1989;17(5):394-398.
51. Carli P, Goldstein P, Lejay M, Facon A, Orliaguet G, Petit P. Remplissage vasculaire prehospitalier en taumatologie: hesteril 6% versus plasmion. Jeur. 2000;13(1-2):101-105.
52. Guidet B, Martinet O, Boulain T, et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care. 2012;16(3):R94.
53. Perner A, Haase N, Guttormsen AB, et al; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367(2):124-134.
54. Myburgh JA, Finfer S, Bellomo R, et al; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367(20):1901-1911.
55. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
56. Falk JL, Rackow EC, Astiz ME, Weil MH. Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol. 1988;28(5):412-415.
57. Randell T, Orko R, Höckerstedt K. Peroperative fluid management of the brain-dead multiorgan donor. Acta Anaesthesiol Scand. 1990;34(7):592-595.
58. Kamann S, Flaig MJ, Korting HC. Hydroxyethyl starch-induced itch: relevance of light microscopic analysis of semi-thin sections and electron microscopy. J Dtsch Dermatol Ges. 2007;5(3):204-208.
59. Sirtl C, Laubenthal H, Zumtobel V, Kraft D, Jurecka W. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth. 1999;82(4):510-515.
60. Rama-Maceiras P, Ingelmo II, Fàbregas JN, Hernández- Palazón J. Fraudulent pain research: a hurt so deep nothing can alleviate it. Rev Esp Anestesiol Reanim. 2009;56(6):372-379.
61. Retraction - Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 2010;375(9713):445.
62. Carlisle JB. The analysis of 168 randomised controlled trials to test data integrity. Anaesthesia. 2012;67(5):521-537.
63. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348(9042):1620-1622.
64. Vermeulen LC Jr, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med. 1995;155(4):373-379.
65. Siegemund M. BaSES Trial: Basel Starch Evaluation in Sepsis. ClinicalTrials.gov 2012; http://clinicaltrials.gov/ct2/show/study/NCT00273728. Accessed October 31, 2012.
66. Sadaka F. The Effect of Three Different Fluids (Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock Patients. ClinicalTrials.gov 2012; http://clinicaltrials.gov/ct2/show/ NCT01319630. Accessed October 31, 2012.